# EdiGene

国内领先CRISPR基因编辑公司；ET-01（β-地中海贫血碱基编辑）处于IND使能阶段；CRISPR HSC项目获NMPA快速通道。

Source: https://cn.bioecon.ru/companies/edigene/
Updated: 2026-06-24

- 国家: China

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 累计募集$164M至$180M | https://www.synbiobeta.com/read/edigene-raises-approximately-usd-62-million-in-series-b-plus-financing-and-expands-operation-locations-to-advance-and-scale-up-clinical-translation-of-gene-editing-technologies |
| 生产基地 | 广东省cGMP生产设施于2018年投产 | https://www.biospace.com/edigene-announces-ind-application-for-its-crispr-cas-9-gene-editing-hematopoietic-stem-cell-therapy-et-01-in-%CE%B2-thalassemia-accepted-for-review-by-china-national-medical-products-administration |
| 监管批准 | ET-01于2021年1月获NMPA的IND批准 | https://thalassaemia.org.cy/news/edigene-announces-approval-in-china-of-its-ind-application-for-crispr-cas-9-gene-editing-therapy-et-01-in-%CE%B2-thalassaemia/, https://www.biospace.com/edigene-announces-ind-application-for-its-crispr-cas-9-gene-editing-hematopoietic-stem-cell-therapy-et-01-in-%CE%B2-thalassemia-accepted-for-review-by-china-national-medical-products-administration, https://www.businesswire.com/news/home/20210118005210/en/EdiGene-Announces-Approval-of-its-IND-Application-for-its-CRISPRCas-9-Gene-editing-Hematopoietic-Stem-Cell-Therapy-ET-01-in--thalassemia-by-China-National-Medical-Products-Administration, https://www.lavfund.com/blog/edigene-announces-approval-of-its-ind-application-for-its-crispr-cas-9 |
| 员工人数 | 截至2026年7月约46名员工 | https://www.caplight.com/company/edigene, https://www.datanyze.com/companies/edigene/399164728 |
| 营收 | 估计年营收介于$1.8M至$50M之间 [中等置信度] | https://www.datanyze.com/companies/edigene/399164728 |

独立来源: biospace.com, businesswire.com, caplight.com, datanyze.com, lavfund.com, synbiobeta.com, thalassaemia.org.cy

## 技术

- [个性化与再生医学](https://cn.bioecon.ru/technology/personalized-regenerative-medicine/)
- [先导编辑](https://cn.bioecon.ru/technology/prime-editing/)
- [基因组编辑](https://cn.bioecon.ru/technology/genome-editing/)
- [碱基编辑](https://cn.bioecon.ru/technology/base-editing/)